Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • KKR will buy Envision...

    KKR will buy Envision Healthcare for 5.57 billion dollar plus debt

    Written by Ruby Khatun Khatun Published On 2018-06-13T09:45:56+05:30  |  Updated On 13 Jun 2018 9:45 AM IST
    KKR will buy Envision Healthcare for 5.57 billion dollar plus debt

    Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital staffing and surgical center company.


    Including debt, the all-cash purchase will value Envision at $9.9 billion, the health-care company said in a statement Monday. Envision said the $46-a-share price represents a 32 percent premium to its stock price in November, when it announced it was reviewing strategic alternatives.


    The review kicked off for the Nashville, Tennessee-based company after activist investor Starboard Value, run by Jeff Smith, revealed a stake and said it would make an attractive takeover target. Corvex Management, another activist firm, and shareholder reduced most of its holdings in the first quarter.


    In the months after the review started, the physician-services provider was said to draw a parade of interested parties looking at all or part of the company. They included strategic buyers such as UnitedHealth Group Inc., as well as private-equity consortiums comprised of Hellman & Friedman, Onex Corp., and Clayton Dubilier & Rice, and one led by Carlyle Group LP.


    KKR is already familiar with Envision. The asset firm’s portfolio company, Air Medical, acquired Envision’s medical transport subsidiary American Medical Response in a $2.4 billion deal announced last year.


    Envision shares rose 2.3 percent Monday to $44.65. The company said the KKR deal values Envision at 10.9 times its adjusted earnings before interest, taxes, depreciation, and amortization for the trailing 12 months.


    Health services assets have become hot targets for buyers.


    Last year, KKR finished raising money for a $1.45 billion health-care fund dedicated to growth stage companies. Health insurance and services giant UnitedHealth has acquired a string of medical practices, and drugstore chain CVS Health Corp. is buying insurer Aetna Inc., with the goal of making CVS’s retail locations hubs for health services. In 2016 Blackstone ended its three-year public-to-private buyout drought with an agreement to buy Team Health Holdings Inc, another health-care staffing company.


    “Envision is a leading provider of physician-led services in a health-care system in which physician-patient interactions have a pronounced impact on nearly all health-care decisions,” Jim Momtazee, KKR’s head of health-care investing, said in the statement. “We are excited to partner with the outstanding team.”


    J.P. Morgan Securities LLC, Evercore Inc., and Guggenheim Securities LLC served as Envision’s financial advisers, while its legal advisers were Wachtell, Lipton, Rosen & Katz, and Bass, Berry & Sims. KKR’s legal counsel was Simpson Thacher & Bartlett LLP.


    Article source: Bloomberg
    buydebtEnvision Healthcare Corphospital staffingJ.P. MorganJim MomtazeeKKRsurgical centerUnitedHealth Group Inc
    Source : Bloomberg

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok